113 related articles for article (PubMed ID: 9647481)
1. Characterization of Ro 04-6790 and Ro 63-0563: potent and selective antagonists at human and rat 5-HT6 receptors.
Sleight AJ; Boess FG; Bös M; Levet-Trafit B; Riemer C; Bourson A
Br J Pharmacol; 1998 Jun; 124(3):556-62. PubMed ID: 9647481
[TBL] [Abstract][Full Text] [Related]
2. Investigation of stretching behaviour induced by the selective 5-HT6 receptor antagonist, Ro 04-6790, in rats.
Bentley JC; Bourson A; Boess FG; Fone KC; Marsden CA; Petit N; Sleight AJ
Br J Pharmacol; 1999 Apr; 126(7):1537-42. PubMed ID: 10323584
[TBL] [Abstract][Full Text] [Related]
3. Involvement of 5-HT6 receptors in nigro-striatal function in rodents.
Bourson A; Boess FG; Bös M; Sleight AJ
Br J Pharmacol; 1998 Dec; 125(7):1562-6. PubMed ID: 9884085
[TBL] [Abstract][Full Text] [Related]
4. The 5-hydroxytryptamine6 receptor-selective radioligand [3H]Ro 63-0563 labels 5-hydroxytryptamine receptor binding sites in rat and porcine striatum.
Boess FG; Riemer C; Bös M; Bentley J; Bourson A; Sleight AJ
Mol Pharmacol; 1998 Sep; 54(3):577-83. PubMed ID: 9730917
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of selective 5-HT6 receptor ligands determined by monitoring 5-HT6 receptor-mediated cAMP signaling pathways.
Romero G; Sánchez E; Pujol M; Pérez P; Codony X; Holenz J; Buschmann H; Pauwels PJ
Br J Pharmacol; 2006 Aug; 148(8):1133-43. PubMed ID: 16865095
[TBL] [Abstract][Full Text] [Related]
6. An assessment of the effects of serotonin 6 (5-HT6) receptor antagonists in rodent models of learning.
Lindner MD; Hodges DB; Hogan JB; Orie AF; Corsa JA; Barten DM; Polson C; Robertson BJ; Guss VL; Gillman KW; Starrett JE; Gribkoff VK
J Pharmacol Exp Ther; 2003 Nov; 307(2):682-91. PubMed ID: 12975483
[TBL] [Abstract][Full Text] [Related]
7. Differences in the central nervous system distribution and pharmacology of the mouse 5-hydroxytryptamine-6 receptor compared with rat and human receptors investigated by radioligand binding, site-directed mutagenesis, and molecular modeling.
Hirst WD; Abrahamsen B; Blaney FE; Calver AR; Aloj L; Price GW; Medhurst AD
Mol Pharmacol; 2003 Dec; 64(6):1295-308. PubMed ID: 14645659
[TBL] [Abstract][Full Text] [Related]
8. Actions of novel agonists, antagonists and antipsychotic agents at recombinant rat 5-HT6 receptors: a comparative study of coupling to G alpha s.
Dupuis DS; Mannoury la Cour C; Chaput C; Verrièle L; Lavielle G; Millan MJ
Eur J Pharmacol; 2008 Jul; 588(2-3):170-7. PubMed ID: 18511034
[TBL] [Abstract][Full Text] [Related]
9. Functional characterization of the recombinant human 5-hydroxytryptamine7(a) receptor isoform coupled to adenylate cyclase stimulation.
Adham N; Zgombick JM; Bard J; Branchek TA
J Pharmacol Exp Ther; 1998 Nov; 287(2):508-14. PubMed ID: 9808674
[TBL] [Abstract][Full Text] [Related]
10. Effects of 5-HT6 antagonists, Ro-4368554 and SB-258585, in tests used for the detection of cognitive enhancement and antipsychotic-like activity.
Gravius A; Laszy J; Pietraszek M; Sághy K; Nagel J; Chambon C; Wegener N; Valastro B; Danysz W; Gyertyán I
Behav Pharmacol; 2011 Apr; 22(2):122-35. PubMed ID: 21301322
[TBL] [Abstract][Full Text] [Related]
11. N1-arylsulfonyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole derivatives are potent and selective 5-HT6 receptor antagonists.
Cole DC; Ellingboe JW; Lennox WJ; Mazandarani H; Smith DL; Stock JR; Zhang G; Zhou P; Schechter LE
Bioorg Med Chem Lett; 2005 Jan; 15(2):379-83. PubMed ID: 15603958
[TBL] [Abstract][Full Text] [Related]
12. Effects of altered 5-ht6 expression in the rat: functional studies using antisense oligonucleotides.
Sleight AJ; Monsma FJ; Borroni E; Austin RH; Bourson A
Behav Brain Res; 1996; 73(1-2):245-8. PubMed ID: 8788511
[TBL] [Abstract][Full Text] [Related]
13. In the search for selective ligands of 5-HT5, 5-HT6 and 5-HT7 serotonin receptors.
Wesołowska A
Pol J Pharmacol; 2002; 54(4):327-41. PubMed ID: 12523486
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and pharmacological characterization of novel 6-fluorochroman derivatives as potential 5-HT1A receptor antagonists.
Yasunaga T; Kimura T; Naito R; Kontani T; Wanibuchi F; Yamashita H; Nomura T; Tsukamoto S; Yamaguchi T; Mase T
J Med Chem; 1998 Jul; 41(15):2765-78. PubMed ID: 9667967
[TBL] [Abstract][Full Text] [Related]
15. Two novel and selective nonimidazole histamine H3 receptor antagonists A-304121 and A-317920: I. In vitro pharmacological effects.
Esbenshade TA; Krueger KM; Miller TR; Kang CH; Denny LI; Witte DG; Yao BB; Fox GB; Faghih R; Bennani YL; Williams M; Hancock AA
J Pharmacol Exp Ther; 2003 Jun; 305(3):887-96. PubMed ID: 12606603
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological study of 3-(phenylsulfonyl)thieno[2,3-e][1,2,3]triazolo[1,5-a]pyrimidines as potent and selective serotonin 5-HT6 receptor antagonists.
Ivachtchenko AV; Golovina ES; Kadieva MG; Koryakova AG; Kovalenko SM; Mitkin OD; Okun IM; Ravnyeyko IM; Tkachenko SE; Zaremba OV
Bioorg Med Chem; 2010 Jul; 18(14):5282-90. PubMed ID: 20541425
[TBL] [Abstract][Full Text] [Related]
17. Conformationally constrained N1-arylsulfonyltryptamine derivatives as 5-HT6 receptor antagonists.
Cole DC; Lennox WJ; Stock JR; Ellingboe JW; Mazandarani H; Smith DL; Zhang G; Tawa GJ; Schechter LE
Bioorg Med Chem Lett; 2005 Nov; 15(21):4780-5. PubMed ID: 16125933
[TBL] [Abstract][Full Text] [Related]
18. Selective 5-HT6 receptor ligands: progress in the development of a novel pharmacological approach to the treatment of obesity and related metabolic disorders.
Heal DJ; Smith SL; Fisas A; Codony X; Buschmann H
Pharmacol Ther; 2008 Feb; 117(2):207-31. PubMed ID: 18068807
[TBL] [Abstract][Full Text] [Related]
19. Novel derivatives of 2-pyridinemethylamine as selective, potent, and orally active agonists at 5-HT1A receptors.
Vacher B; Bonnaud B; Funes P; Jubault N; Koek W; Assié MB; Cosi C; Kleven M
J Med Chem; 1999 May; 42(9):1648-60. PubMed ID: 10229633
[TBL] [Abstract][Full Text] [Related]
20. The agonist activities of the putative antipsychotic agents, L-745,870 and U-101958 in HEK293 cells expressing the human dopamine D4.4 receptor.
Gazi L; Bobirnac I; Danzeisen M; Schüpbach E; Bruinvels AT; Geisse S; Sommer B; Hoyer D; Tricklebank M; Schoeffter P
Br J Pharmacol; 1998 Jul; 124(5):889-96. PubMed ID: 9692773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
